Pharmacy benefit managers (PBMs) have become a major focus of healthcare policy, as policymakers, regulators, and other stakeholders debate the industry’s business practices and models. Congress addressed PBM…
Read more
On June 24, 2026, the Centers for Medicare & Medicaid Services (CMS) issued the End-Stage Renal Disease (ESRD) Prospective Payment System (PPS) proposed rule (CMS-1846-P) for calendar year…
Read more
On May 7, the Medicaid and CHIP Payment and Access Commission (MACPAC) held a public meeting, which included votes on recommendations on the following topics. All but three…
Read more
As Applied Policy has previously reported, in 2025, the Centers for Medicare & Medicaid Services (CMS) announced an ambitious suite of drug pricing models designed to align what…
Read more
On April 10, 2026, the Centers for Medicare & Medicaid Services (CMS) issued the Interoperability Standards and Prior Authorization for Drugs proposed rule, along with a fact sheet…
Read more
On April 2, 2026, the White House released the President’s fiscal year (FY) 2027 budget. A summary of the HHS FY 2027 Budget in Brief is below, and…
Read more
A year after President Trump issued Executive Order (EO) 14273, Lowering Drug Prices by Once Again Putting Americans First, federal agencies continue to take steps to advance its…
Read more
On April 2, 2026, the Centers for Medicare & Medicaid Services (CMS) issued the fiscal year (FY) 2027 proposed Medicare Program; FY 2027 Hospice Wage Index and Payment…
Read more
Each March, the Medicare Payment Advisory Commission (MedPAC) is required to report to Congress on the Medicare fee-for-service (FFS) payment systems, the Medicare Advantage (MA) program, and the…
Read more
On March 5 and 6, 2026, the Medicaid and Children’s Health Insurance Program (CHIP) Payment and Access Commission (MACPAC) held a public meeting, which included the following sessions:…
Read more
On March 2 and 3, 2026, the Medicare Payment Advisory Commission (MedPAC) held a public meeting, which included the following sessions: Access to hospice and certain complex palliative…
Read more
Although we are less than halfway through winter, we have already seen significant activity in drug pricing. In this article, we explore what has happened in recent months…
Read more